Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Biomarkers returned 31 record(s)
|
|
Monday, 07/30/2018
|
Statistical Challenges in Developing Data-Driven Discovery, Diagnosis, and Treatment of Psychiatric Diseases
Thaddeus Tarpey, Wright State University
|
Statistical Methods for Pooling Categorical Biomarkers from Multiple Studies
Xiao Wu, Harvard University; Molin Wang, Harvard T.H. Chan School of Public Health
11:20 AM
|
Identifying Biomarkers in Heterogeneous Samples Without Known Reference Cell Type Profiles
Kelly Mosesso, Harvard University ; Martin Aryee, Harvard University
11:35 AM
|
Maximum Diversity Weighting for Biomarkers with Application in HIV-1 Vaccine Studies
Zonglin He, Fred Hutchinson Cancer Research Center; Youyi Fong, Fred Hutchinson Cancer Research Center
11:55 AM
|
Bessel Functions and the Ordering of Changes in Biomarkers, with Application to the Hypothesized Biomarker Model in Preclinical Alzheimer Disease
Chengjie Xiong, Washington University in St Louis; Jingqin Luo, Washington University; John Morris, Washington University
12:05 PM
|
A Generalized Design for a Confirmatory Basket Trial
Robert Beckman, Georgetown University; Xiaoyun (Nicole) Li, Merck
2:25 PM
|
Bayesian Latent Hierarchical Model for Transcriptomic Meta-Analysis to Detect Biomarkers with Clustered Meta-Patterns of Differential Expression Signals
Zhiguang Huo, University of Florida; Chi Song, Ohio State University; George Tseng, University of Pittsburgh
3:05 PM
|
|
Tuesday, 07/31/2018
|
Analysis Framework in Integrating Data of Different Modalities with Application in Identifying Important Predictors/Subgroups in Non-Alcoholic Steatohepatitis
Tuan Nguyen, Gilead Sciences; Guang Chen, Gilead Sciences; Adarsh Joshi, Gilead Sciences, Inc.; Lulu Wang, Gilead Sciences; Yafeng Zhang, Gilead Sciences; Yuanyuan Xiao, Gilead Sciences; Catherine Jia, Gilead Sciences; Ren Xu, Gilead Sciences; Stephen Djedjos, Gilead Sciences; Rob Myers, Gilead Sciences
|
Determination of Optimal Cut-Off Points for Biomarkers in Oncology Research
Shu-Pang Huang, Bristol-Myers Squibb Co.; Tian Chen, Bristol-Myers Squibb Co.; Ye Feng, Bristol-Myers Squibb Co.; Ming Zhou, Bristol-Myers Squibb Company; Ramachandran Suresh, Bristol-Myers Squibb Co.
|
Variable Selection May Be Overrated
Tristan Grogan, UCLA; David Elashoff, UCLA
|
Discovering Biomarkers Jointly Modeled with Multiple Efficacy Variables in Early Phase Clinical Trials
Danni Yu, Eli Lilly and Company
|
A Two-Stage Method to Analyze Multivariate Cluster Biomarkers in Prediction on a Single Binary Outcome
Xiaoying Yu, University of Texas Medical Branch at Galveston; Wenyaw Chan, University of Texas Health Science Center at Houston; Gracie Vargas, University of Texas Medical Branch at Galveston; Rahul Pal, University of Texas Medical Branch at Galveston
|
Robust Combination of Biomarkers for Classification with Covariate Adjustment
Ying Huang, Fred Hutchinson Cancer Research Center; Soyoung Kim, Medical College of Wisconsin
8:55 AM
|
Discovering Biomarkers Jointly Modeled with Multiple Efficacy Variables in Early Phase Clinical Trials
Danni Yu, Eli Lilly and Company
9:10 AM
|
WITHDRAWN: Combining Biomarkers to Improve Classification Accuracy Under Heterogeneous Transformations
Aiyi Liu, BBB/DIPHR/NICHD; Wei Zhang, BBB/DIPHR/NICHD
9:15 AM
|
Improved Selection of High-Dimensional Neuroimaging Biomarkers Associated with Neurodegenerative Disease Progression
Tanya Garcia, Texas A&M University; Jeffrey S Morris, The University of Texas M.D. Anderson Cancer Center
9:15 AM
|
New Dimension Reduction Methods for Combining Longitudinally Measured Biomarkers
Ruth Pfeiffer , National Cancer Institute; Wei Wang , George Washington University ; Efstathia Bura , Vienna University of Technology
9:35 AM
|
A Multi-Step Classifier Addressing Cohort Heterogeneity Improves Performance of Prognostic Biomarkers in Three Cancer Types
Ellis Patrick, University of Sydney; Samuel Mueller, The University of Sydney; Jean Yee Hwa Yang, University of Sydney, Australia
9:35 AM
|
Assessment of Biomarkers and Surrogate Endpoints in Drug Development
Ivan Chan, AbbVie Inc; Shu-Chih Su, Merck Research Labs
10:55 AM
|
A Two-Stage Method to Analyze Multivariate Cluster Biomarkers in Prediction on a Single Binary Outcome
Xiaoying Yu, University of Texas Medical Branch at Galveston; Wenyaw Chan, University of Texas Health Science Center at Houston; Gracie Vargas, University of Texas Medical Branch at Galveston; Rahul Pal, University of Texas Medical Branch at Galveston
11:10 AM
|
Confidence intervals to compare optimal performance in multi-State diagnostic tests with correlated Biomarkers
Beau Nunnally, Air Force Institute of Technology; Christine M Schubert, Air Force Institute of Technology; Katherine A Batterton, Air Force Institute of Technology
3:20 PM
|
|
Thursday, 08/02/2018
|
Dynamic Prediction of Competing Risk Events using Landmark Sub-distribution Hazard Model with Multivariate Longitudinal Biomarkers
Cai Wu, Merck & Co.; Liang Li, UT MD Anderson Cancer Center; Ruosha Li, University of Texas School of Public Health
8:50 AM
|
Evaluating Biomarkers for Prognostic Enrichment of Clinical Trials
Kathleen F. Kerr, University of Washington; Jeremy Roth, University of Washington; Kehao Zhu, Axio Research; Heather Thiessen-Philbrook, Yale University; Allison Meisner, Johns Hopkins University; Francis Perry Wilson, Yale University; Steven Coca, Icahn School of Medicine at Mount Sinai; Chirag Parikh, Yale University
10:35 AM
|
Bias-Corrected Estimation of Treatment Effects in Biomarker-Based Adaptive Subgroup Analysis: New Approach Based on Randomized Tests with Smooth Rejection Function
Kiichiro Toyoizumi, Shionogi Inc.; Shigeyuki Matsui, Nagoya University
11:05 AM
|
|
|
